Sajad Najafi

2.5k total citations
76 papers, 1.7k citations indexed

About

Sajad Najafi is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Sajad Najafi has authored 76 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Molecular Biology, 41 papers in Cancer Research and 12 papers in Oncology. Recurrent topics in Sajad Najafi's work include Cancer-related molecular mechanisms research (31 papers), MicroRNA in disease regulation (25 papers) and Circular RNAs in diseases (25 papers). Sajad Najafi is often cited by papers focused on Cancer-related molecular mechanisms research (31 papers), MicroRNA in disease regulation (25 papers) and Circular RNAs in diseases (25 papers). Sajad Najafi collaborates with scholars based in Iran, United States and Iraq. Sajad Najafi's co-authors include Keywan Mortezaee, Jamal Majidpoor, Seyed Mohsen Aghaei Zarch, Mohammad Taheri, Bashdar Mahmud Hussen, Soudeh Ghafouri‐Fard, Yahya Asemani, Shahin Aghamiri, Yazdan Rahmati and Maryam Farzaneh and has published in prestigious journals such as Gene, Experimental Cell Research and Life Sciences.

In The Last Decade

Sajad Najafi

73 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sajad Najafi Iran 28 1.2k 903 241 213 102 76 1.7k
Zhuoran Zhang China 18 805 0.7× 611 0.7× 160 0.7× 243 1.1× 86 0.8× 36 1.2k
Valerie B. Sampson United States 16 1.0k 0.8× 679 0.8× 263 1.1× 82 0.4× 78 0.8× 23 1.4k
Mengmeng Guo China 26 1.0k 0.8× 636 0.7× 176 0.7× 446 2.1× 59 0.6× 76 1.6k
Ye Zhang China 24 1.1k 0.9× 665 0.7× 185 0.8× 132 0.6× 60 0.6× 93 1.6k
Yuanyuan Liu China 18 2.2k 1.8× 1.1k 1.2× 256 1.1× 219 1.0× 38 0.4× 47 2.6k
Ji‐Liang Li China 17 914 0.8× 609 0.7× 291 1.2× 173 0.8× 49 0.5× 41 1.6k
Yongkang Yang China 21 704 0.6× 412 0.5× 212 0.9× 414 1.9× 43 0.4× 48 1.3k
Pai‐Sheng Chen Taiwan 16 1.4k 1.1× 783 0.9× 244 1.0× 126 0.6× 53 0.5× 37 1.8k
Dongliang Chen China 21 1.4k 1.2× 630 0.7× 167 0.7× 78 0.4× 161 1.6× 67 1.9k
Shuanglin Xiang China 25 1.1k 0.9× 519 0.6× 202 0.8× 191 0.9× 87 0.9× 73 1.7k

Countries citing papers authored by Sajad Najafi

Since Specialization
Citations

This map shows the geographic impact of Sajad Najafi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sajad Najafi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sajad Najafi more than expected).

Fields of papers citing papers by Sajad Najafi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sajad Najafi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sajad Najafi. The network helps show where Sajad Najafi may publish in the future.

Co-authorship network of co-authors of Sajad Najafi

This figure shows the co-authorship network connecting the top 25 collaborators of Sajad Najafi. A scholar is included among the top collaborators of Sajad Najafi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sajad Najafi. Sajad Najafi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Azizidoost, Shirin, et al.. (2024). The Role of Long Non-Coding RNAs in the Pathogenesis of EssentialHypertension. Current Signal Transduction Therapy. 19(2). 1 indexed citations
3.
4.
Zarch, Seyed Mohsen Aghaei, et al.. (2024). A review of the advances, insights, and prospects of gene therapy for Alzheimer’s disease: A novel target for therapeutic medicine. Gene. 912. 148368–148368. 5 indexed citations
5.
Ghaneialvar, Hori, et al.. (2024). Combining anti-checkpoint immunotherapies and cancer vaccines as a novel strategy in oncological therapy: A review. Human Immunology. 86(1). 111209–111209. 3 indexed citations
6.
Fattahi, Mehdi, Delsuz Rezaee, Saeid Bagheri‐Mohammadi, et al.. (2023). microRNA-382 as a tumor suppressor? Roles in tumorigenesis and clinical significance. International Journal of Biological Macromolecules. 250. 125863–125863. 36 indexed citations
7.
Najafi, Sajad, Jamal Majidpoor, & Keywan Mortezaee. (2023). Extracellular vesicle–based drug delivery in cancer immunotherapy. Drug Delivery and Translational Research. 13(11). 2790–2806. 41 indexed citations
8.
Bagheri‐Mohammadi, Saeid, et al.. (2023). The mitochondrial calcium signaling, regulation, and cellular functions: A novel target for therapeutic medicine in neurological disorders. Journal of Cellular Biochemistry. 124(5). 635–655. 12 indexed citations
9.
Khosravifar, Mina, Alireza Mohammadzadeh, Sajad Najafi, et al.. (2023). MicroRNA-122 in human cancers: from mechanistic to clinical perspectives. Cancer Cell International. 23(1). 29–29. 72 indexed citations
10.
Najafi, Sajad & Keywan Mortezaee. (2023). Modifying CAR-T cells with anti-checkpoints in cancer immunotherapy: A focus on anti PD-1/PD-L1 antibodies. Life Sciences. 338. 122387–122387. 21 indexed citations
11.
Zendehdel, Rezvan, et al.. (2023). The emerging potential of green-synthesized nanoparticles as colorimetric sensors for ammonia detection. Microchemical Journal. 196. 109646–109646. 6 indexed citations
12.
Rezaee, Delsuz, et al.. (2023). The role of microRNA-185 in the pathogenesis of human diseases: A focus on cancer. Pathology - Research and Practice. 249. 154729–154729. 30 indexed citations
13.
Najafi, Sajad & Keywan Mortezaee. (2023). Advances in dendritic cell vaccination therapy of cancer. Biomedicine & Pharmacotherapy. 164. 114954–114954. 60 indexed citations
14.
Sayad, Arezou, Sajad Najafi, Bashdar Mahmud Hussen, et al.. (2022). The role of circular RNAs in pancreatic cancer: new players in tumorigenesis and potential biomarkers. Pathology - Research and Practice. 232. 153833–153833. 22 indexed citations
15.
Najafi, Sajad, Seyyed Hossein Khatami, Marjan Khorsand, et al.. (2022). Long non-coding RNAs (lncRNAs); roles in tumorigenesis and potentials as biomarkers in cancer diagnosis. Experimental Cell Research. 418(2). 113294–113294. 52 indexed citations
16.
Letafati, Arash, Sajad Najafi, Mohammad Reza Karimzadeh, et al.. (2022). MicroRNA let-7 and viral infections: focus on mechanisms of action. Cellular & Molecular Biology Letters. 27(1). 14–14. 89 indexed citations
17.
Asemani, Yahya, Sajad Najafi, Fatemeh Ezzatifar, Naime Majidi Zolbanin, & Reza Jafari. (2022). Recent highlights in the immunomodulatory aspects of Treg cell-derived extracellular vesicles: special emphasis on autoimmune diseases and transplantation. Cell & Bioscience. 12(1). 67–67. 29 indexed citations
18.
Ghafouri‐Fard, Soudeh, Sajad Najafi, Bashdar Mahmud Hussen, et al.. (2022). The Role of Circular RNAs in the Carcinogenesis of Bladder Cancer. Frontiers in Oncology. 12. 801842–801842. 27 indexed citations
19.
Najafi, Sajad, et al.. (2021). MiR-574-5P, miR-1827, and miR-4429 as Potential Biomarkers for Schizophrenia. Journal of Molecular Neuroscience. 72(2). 226–238. 25 indexed citations
20.
Aghamiri, Shahin, Pourya Raee, Mohammad‐Amin Abdollahifar, et al.. (2021). Antimicrobial peptides as potential therapeutics for breast cancer. Pharmacological Research. 171. 105777–105777. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhuoran Zhang Breakdown of academic impact, for papers by Valerie B. Sampson Breakdown of academic impact, for papers by Mengmeng Guo Breakdown of academic impact, for papers by Ye Zhang Breakdown of academic impact, for papers by Yuanyuan Liu Breakdown of academic impact, for papers by Ji‐Liang Li Breakdown of academic impact, for papers by Yongkang Yang Breakdown of academic impact, for papers by Pai‐Sheng Chen Breakdown of academic impact, for papers by Dongliang Chen Breakdown of academic impact, for papers by Shuanglin Xiang
Rankless by CCL
2026